Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMM9ORD)

Drug Name
ASG-15ME Drug Info
Indication
Disease Entry ICD 11 Status REF
Bladder cancer 2C94 Phase 1 [1]
Urothelial carcinoma 2C92.0 Phase 1 [2]
Cross-matching ID
TTD Drug ID
DMM9ORD

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
SLIT and NTRK-like family member 6 (SLITRK6) TTTVEKI SLIK6_HUMAN Not Available [3]

References

1 ClinicalTrials.gov (NCT01963052) ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of Seattle Genetics.